Alzahrani, T
If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit, delay or cease the commercialization of our products
In particular, a dual-action combination drug has been developed and approved for use, which is simultaneously an agonist of GLP-1 and GIP receptors tirzepatide (see Table 2)
Unknowns (the big ones) Long-term safety: The longest trial data we have is 68 weeks
Will you get sick if you use your semaglutide after the expiration date has passed
Higher, weight-focused titration protocols aim at appetite regulation and sustained caloric change, which produces larger average weight losses under trial conditions, and Healthline reports Ozempic has been shown to reduce body weight by an average of 14.9% over 68 weeks , a figure that reflects a specific study population and schedule